Back to search results

Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Esophageal Squamous Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • UPMC Hillman Cancer Center ( Site 1904), Pittsburgh, Pennsylvania, United States

    Study coordinator · 412-623-8974

  • Liga Norte Riograndense Contra o Cancer ( Site 1301), Natal, Rio Grande do Norte, Brazil

    Study coordinator · +55 84 4009-5595

  • Hospital Nossa Senhora da Conceicao ( Site 1300), Porto Alegre, Rio Grande do Sul, Brazil

    Study coordinator · +555133572092

  • ICESP - INSTITUTO DO CÂNCER DO ESTADO DE SÃO PAULO ( Site 1302), São Paulo, Brazil

    Study coordinator · 551138932000

  • Clínica Puerto Montt ( Site 1406), Port Montt, Los Lagos Region, Chile

    Study coordinator · +56652484800

  • FALP ( Site 1400), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56224205098

  • Centro de Oncología de Precisión ( Site 1402), Santiago, Region M. de Santiago, Chile

    Study coordinator · 56225189885

  • Clínica UC San Carlos de Apoquindo ( Site 1403), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56223748924

  • Bradfordhill ( Site 1401), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56220490970

  • Bradford Hill Norte ( Site 1405), Antofagasta, Chile

    Study coordinator · +56442023631

  • The Second Affiliated Hospital of Anhui Medical University ( Site 9511), Hefei, Anhui, China

    Study coordinator · 0551-63839536

  • Beijing Cancer Hospital ( Site 9500), Beijing, Beijing Municipality, China

    Study coordinator · (010)88196317

  • The First Affiliated Hospital of Xiamen University ( Site 9503), Xiamen, Fujian, China

    Study coordinator · 0592-2139767

  • Henan Cancer Hospital ( Site 9509), Zhengzhou, Henan, China

    Study coordinator · 0371-65587625

  • Xuzhou Central Hospital ( Site 9512), Xuzhou, Jiangsu, China

    Study coordinator · 86051680812397

  • The First Affiliated Hospital of Nanchang University ( Site 9505), Nanchang, Jiangxi, China

    Study coordinator · 86079188692201

  • Masarykuv onkologicky ustav-Klinika komplexni onkologicke pece ( Site 9000), Brno, Brno-mesto, Czechia

    Study coordinator · +420543136812

  • C.H.R.U. de Brest - Hopital Cavale Blanche ( Site 9104), Brest, Finistere, France

    Study coordinator · 33298223428

  • CHU Lille - Institut Coeur Poumon ( Site 9100), Lille, Nord, France

    Study coordinator · +33320445461

  • Pitie Salpetriere University Hospital ( Site 9102), Paris, France

    Study coordinator · +331 42 16 10 41

  • Universitaetsklinikum Duesseldorf ( Site 1808), Düsseldorf, North Rhine-Westphalia, Germany

    Study coordinator · +492118108751

  • Universitätsklinikum Carl Gustav Carus - Medical Oncology ( Site 1806), Dresden, Saxony, Germany

    Study coordinator · +493514583016

  • Haematologisch-Onkologische Praxis Eppendorf Facharztzentrum Eppendorf - Hope ( Site 1807), Hamburg, Germany

    Study coordinator · +4940360352246

  • Ospedale San Raffaele-Oncologia Medica ( Site 9201), Milan, Lombardy, Italy

    Study coordinator · +390226437615

  • Istituto Oncologico Veneto IRCCS ( Site 9202), Padova, Veneto, Italy

    Study coordinator · 390498215910

  • Aichi Cancer Center ( Site 9702), Nagoya, Aichi-ken, Japan

    Study coordinator · +81-52-762-6111

  • National Cancer Center Hospital East ( Site 9701), Kashiwa, Chiba, Japan

    Study coordinator · +81-4-7133-1111

  • National Cancer Center Hospital ( Site 9700), Chūō, Tokyo, Japan

    Study coordinator · +81-3-3542-2511

  • Oslo Universitetssykehus Radiumhospitalet ( Site 1501), Oslo, Norway

    Study coordinator · +4723026600

  • National University Hospital ( Site 9800), Singapore, Central Singapore, Singapore

    Study coordinator · +65 6908 2222

  • National Cancer Center ( Site 9902), Goyang-si, Kyonggi-do, South Korea

    Study coordinator · +82319201694

  • Asan Medical Center ( Site 9901), Seoul, South Korea

    Study coordinator · +82230107179

  • Samsung Medical Center ( Site 9900), Seoul, South Korea

    Study coordinator · +82234106518

  • Kantonsspital Graubuenden ( Site 1700), Chur, Kanton Graubünden, Switzerland

    Study coordinator · +41 81 256 61 11

  • Hopitaux Universitaires de Geneve HUG. ( Site 1701), Geneva, Switzerland

    Study coordinator · +41 (0)22 372 95 77

  • Kaohsiung Medical University Chung-Ho Memorial Hospital ( Site 1009), Kaoshiung, Kaohsiung, Taiwan

    Study coordinator · +8867-3121101#7451

  • Kaohsiung Chang Gung Memorial Hospital ( Site 1003), Kaohsiung City, Taiwan

    Study coordinator · +88677317123x3679

  • China Medical University Hospital ( Site 1007), Taichung, Taiwan

    Study coordinator · 886-4-22052121

  • National Cheng Kung University Hospital ( Site 1001), Tainan, Taiwan

    Study coordinator · +88662353535x4559

  • National Taiwan University Hospital ( Site 1000), Taipei, Taiwan

    Study coordinator · +886223123456x67680

  • Taipei Veterans General Hospital ( Site 1005), Taipei, Taiwan

    Study coordinator · +886228712121

  • Chang Gung Memorial Hospital - Linkou Branch ( Site 1006), Taoyuan, Taiwan

    Study coordinator · +88633281200 #8825

  • Ramathibodi Hospital ( Site 1103), Ratchathewi, Bangkok, Thailand

    Study coordinator · +6622004029

  • Songklanagarind hospital ( Site 1101), Hat Yai, Changwat Songkhla, Thailand

    Study coordinator · +6674451469
Study leads

  • Medical Director

    Study Director

    Merck Sharp & Dohme LLC

View source on ClinicalTrials.gov(opens in a new tab)